{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:30:02Z","timestamp":1791228602784,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T00:00:00Z","timestamp":1543190400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004045","name":"Karadeniz Technical University","doi-asserted-by":"publisher","award":["5663"],"award-info":[{"award-number":["5663"]}],"id":[{"id":"10.13039\/501100004045","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comprehensive Psychiatry"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.comppsych.2018.11.013","type":"journal-article","created":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T21:35:58Z","timestamp":1545341758000},"page":"61-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"special_numbering":"C","title":["Blood levels of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha and cognitive functions in patients with obsessive compulsive disorder"],"prefix":"10.1016","volume":"89","author":[{"given":"Evrim \u00d6zkorumak","family":"Karag\u00fczel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filiz Civil","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emel Korkmaz","family":"Uysal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selim","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demet Sa\u011flam","family":"Aykut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Tat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00fcleyman Caner","family":"Karahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.comppsych.2018.11.013_bb0005","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.psc.2006.02.003","article-title":"Immunology of obsessive\u2013compulsive disorder","volume":"29","author":"Murphy","year":"2006","journal-title":"Psychiatr Clin North Am"},{"key":"10.1016\/j.comppsych.2018.11.013_bb0010","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.biopsych.2007.09.024","article-title":"Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review","volume":"63","author":"Potvin","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.comppsych.2018.11.013_bb0015","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.comppsych.2018.11.013_bb0020","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s11920-012-0272-0","article-title":"Systematic review of proinflammatory cytokines in obsessive-compulsive disorder","volume":"14","author":"Gray","year":"2012","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.comppsych.2018.11.013_bb0025","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2147\/IJICMR.S76710","article-title":"The cytokine profile of OCD: pathophysiological insights","volume":"7","author":"Marazziti","year":"2015","journal-title":"Int J Interf Cytokine Mediator Res"},{"issue":"3","key":"10.1016\/j.comppsych.2018.11.013_bb0030","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.psychres.2015.07.009","article-title":"Plasma cytokine abnormalities in drug-na\u00efve, comorbidity-free obsessive\u2013compulsive disorder","volume":"229","author":"Rao","year":"2015","journal-title":"Psychiatry Res"},{"issue":"2\u20133","key":"10.1016\/j.comppsych.2018.11.013_bb0035","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000356554","article-title":"Searching for the immune basis of obsessive-compulsive disorder","volume":"21","author":"Teixeira","year":"2014","journal-title":"Neuroimmunomodulation"},{"issue":"3","key":"10.1016\/j.comppsych.2018.11.013_bb0040","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.neubiorev.2008.10.005","article-title":"Evidence for a cytokine model of cognitive function","volume":"33","author":"McAfoose","year":"2009","journal-title":"Neurosci Biobehav Rev"},{"issue":"6","key":"10.1016\/j.comppsych.2018.11.013_bb0045","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1017\/S0033291713001803","article-title":"Cognitive functioning in obsessive-compulsive disorder: a meta-analysis","volume":"44","author":"Shin","year":"2014","journal-title":"Psychol Med"},{"issue":"5","key":"10.1016\/j.comppsych.2018.11.013_bb0050","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1440-1819.2005.01411.x","article-title":"Persistent cognitive dysfunction in patients with obsessive-compulsive disorder: a naturalistic study","volume":"59","author":"Roh","year":"2005","journal-title":"Psychiatry Clin Neurosci"},{"issue":"1","key":"10.1016\/j.comppsych.2018.11.013_bb0055","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0005-7967(01)00101-2","article-title":"Two different types of obsession: autogenous obsessions and reactive obsessions","volume":"41","author":"Lee","year":"2003","journal-title":"Behav Res Ther"},{"key":"10.1016\/j.comppsych.2018.11.013_bb0060","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/0264830500381435","article-title":"The immune system and neu-ropsychiatric diseases","volume":"17","author":"Kerr","year":"2005","journal-title":"Int Rev Psychiatry"},{"key":"10.1016\/j.comppsych.2018.11.013_bb0065","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0006-3223(98)00371-0","article-title":"Immunological alterations in adult obsessive-compulsive disorder","volume":"46","author":"Marazziti","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.comppsych.2018.11.013_bb0070","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.neubiorev.2016.09.025","article-title":"The link between autoimmune diseases and obsessive-compulsive and tic disorders: a systematic review","volume":"71","author":"Perez-Vigil","year":"2016","journal-title":"Neurosci Biobehav Rev"},{"issue":"5","key":"10.1016\/j.comppsych.2018.11.013_bb0075","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1176\/appi.ajp.157.5.683","article-title":"Cytokines and the brain: implications for clinical psychiatry","volume":"157","author":"Kronfol","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.comppsych.2018.11.013_bb0080","doi-asserted-by":"crossref","first-page":"65704","DOI":"10.1155\/2007\/65704","article-title":"Plasma levels of tumor necrosis factor-alpha and Interleukin-6 in obsessive compulsive disorder","volume":"2007","author":"Konuk","year":"2007","journal-title":"Mediators Inflamm"},{"issue":"2","key":"10.1016\/j.comppsych.2018.11.013_bb0085","first-page":"157","article-title":"Serum IL-1, IL-2, IL-4, IL-6, IL-10, TNF-\u03b1, and IFN-\u03b3 levels in drug-free, comorbidity-free obsessive-compulsive disorder patients","volume":"19","author":"Erbay","year":"2018","journal-title":"Anadolu Psikiyatri Derg"},{"key":"10.1016\/j.comppsych.2018.11.013_bb0090","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000026500","article-title":"Decreased blood levels of tumor necrosis factor-alpha in patients with obsessive-compulsive disorder","volume":"37","author":"Monteleone","year":"1998","journal-title":"Neuropsychobiology"},{"issue":"10","key":"10.1016\/j.comppsych.2018.11.013_bb0095","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.biopsych.2010.06.012","article-title":"A meta-analysis of cytokines in Alzheimer's disease","volume":"68","author":"Swardfager","year":"2010","journal-title":"Biol Psychiatry"},{"issue":"12","key":"10.1016\/j.comppsych.2018.11.013_bb0100","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/mp.2016.3","article-title":"A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression","volume":"21","author":"Goldsmith","year":"2016","journal-title":"Mol Psychiatry"},{"issue":"6","key":"10.1016\/j.comppsych.2018.11.013_bb0105","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/01.psy.0000238451.22174.92","article-title":"Interleukin-6 covaries inversely with cognitive performance among middle-aged community volunteers","volume":"68","author":"Marsland","year":"2006","journal-title":"Psychosom Med"},{"key":"10.1016\/j.comppsych.2018.11.013_bb0110","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.exger.2004.01.009","article-title":"Inflammatory mediators in the elderly","volume":"39","author":"Krabbe","year":"2004","journal-title":"Exp Gerontol"},{"issue":"11","key":"10.1016\/j.comppsych.2018.11.013_bb0115","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0006-3223(96)00495-7","article-title":"Plasma interleukin-1\u03b2 and tumor necrosis factor concentrations in obsessive-compulsive disorders","volume":"42","author":"Brambilla","year":"1997","journal-title":"Biol Psychiatry"},{"issue":"6","key":"10.1016\/j.comppsych.2018.11.013_bb0120","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.comppsych.2011.12.007","article-title":"A cytokine study of adult patients with obsessive-compulsive disorder","volume":"53","author":"Fontenelle","year":"2012","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.comppsych.2018.11.013_bb0125","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.2044-8341.1934.tb01129.x","article-title":"The psychopathology of insight","volume":"14","author":"Lewis","year":"1934","journal-title":"Br J Med Psychol"},{"issue":"2","key":"10.1016\/j.comppsych.2018.11.013_bb0130","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.schres.2017.04.015","article-title":"Cytokines and C-reactive protein alterations with respect to cognitive impairment in schizophrenia and bipolar disorder: a systematic review","volume":"192","author":"Misiak","year":"2018","journal-title":"Schizophr Res"},{"issue":"12","key":"10.1016\/j.comppsych.2018.11.013_bb0135","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1046\/j.1532-5415.2002.50619.x","article-title":"Cytokines and cognition-the case for a head-to-toe inflammatory paradigm","volume":"50","author":"Wilson","year":"2002","journal-title":"J Am Geriatr Soc"},{"issue":"8","key":"10.1016\/j.comppsych.2018.11.013_bb0140","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1212\/01.WNL.0000158281.08946.68","article-title":"Serum inflammatory proteins and cognitive decline in older persons","volume":"64","author":"Dik","year":"2005","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.comppsych.2018.11.013_bb0145","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.biopsycho.2003.07.007","article-title":"Neuropsychological performance in obsessive-compulsive disorder: a critical review","volume":"65","author":"Kuelz","year":"2004","journal-title":"Biol Psychol"},{"issue":"9","key":"10.1016\/j.comppsych.2018.11.013_bb0150","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s11920-016-0720-3","article-title":"Cognitive dysfunction in obsessive-compulsive disorder","volume":"18","author":"Benzina","year":"2016","journal-title":"Curr Psychiatry Rep"},{"issue":"2","key":"10.1016\/j.comppsych.2018.11.013_bb0155","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/hup.2301","article-title":"Levels of TNF-\u03b1, soluble TNF receptors (sTNFR1, sTNFR2), and cognition in bipolar disorder","volume":"28","author":"Doganavsargil-Baysal","year":"2013","journal-title":"Hum Psychopharmacol Clin Exp"},{"issue":"1","key":"10.1016\/j.comppsych.2018.11.013_bb0160","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00213-014-3650-y","article-title":"Decreased serum TNF-alpha levels in chronic schizophrenia patients on long-term antipsychotics: correlation with psychopathology and cognition","volume":"232","author":"Lv","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"issue":"5","key":"10.1016\/j.comppsych.2018.11.013_bb0165","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1080\/15622975.2016.1212172","article-title":"Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy","volume":"18","author":"Hori","year":"2017","journal-title":"World J Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.comppsych.2018.11.013_bb0170","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jad.2011.12.034","article-title":"Executive dysfunction in euthymic bipolar disorder patients and its association with plasma biomarkers","volume":"137","author":"Barbosa","year":"2012","journal-title":"J Affect Disord"},{"issue":"1","key":"10.1016\/j.comppsych.2018.11.013_bb0175","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.schres.2015.03.018","article-title":"Elevated C-reactive protein is associated with sensory gating deficit in schizophrenia","volume":"165","author":"Micoulaud-Franchi","year":"2015","journal-title":"Schizophr Res"}],"container-title":["Comprehensive Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010440X18301986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010440X18301986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T13:01:04Z","timestamp":1574859664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010440X18301986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":35,"alternative-id":["S0010440X18301986"],"URL":"https:\/\/doi.org\/10.1016\/j.comppsych.2018.11.013","relation":{},"ISSN":["0010-440X"],"issn-type":[{"value":"0010-440X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood levels of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha and cognitive functions in patients with obsessive compulsive disorder","name":"articletitle","label":"Article Title"},{"value":"Comprehensive Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.comppsych.2018.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}